These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Serum lipids, vitamin B12 and folic acid levels in children receiving long-term valproate therapy. Geda G; Caksen H; Içağasioğlu D Acta Neurol Belg; 2002 Sep; 102(3):122-6. PubMed ID: 12400250 [TBL] [Abstract][Full Text] [Related]
5. Decreased platelet count in children with epilepsy treated with valproate and its relationship to the immature platelet fraction. Kurahashi H; Takami A; Murotani K; Numoto S; Okumura A Int J Hematol; 2018 Jan; 107(1):105-111. PubMed ID: 28879549 [TBL] [Abstract][Full Text] [Related]
6. Thrombocytopenia secondary to high valproate levels in children with epilepsy. Delgado MR; Riela AR; Mills J; Browne R; Roach ES J Child Neurol; 1994 Jul; 9(3):311-4. PubMed ID: 7930412 [TBL] [Abstract][Full Text] [Related]
7. Hematologic manifestations and impaired liver synthetic function during valproate monotherapy. Hauser E; Seidl R; Freilinger M; Male C; Herkner K Brain Dev; 1996; 18(2):105-9. PubMed ID: 8733899 [TBL] [Abstract][Full Text] [Related]
10. Severe hematologic toxicity of valproic acid. A report of four patients. Ganick DJ; Sunder T; Finley JL Am J Pediatr Hematol Oncol; 1990; 12(1):80-5. PubMed ID: 2106802 [TBL] [Abstract][Full Text] [Related]
11. Valproate-mediated disturbances of hemostasis: relationship to dose and plasma concentration. Gidal B; Spencer N; Maly M; Pitterle M; Williams E; Collins M; Jones J Neurology; 1994 Aug; 44(8):1418-22. PubMed ID: 8058141 [TBL] [Abstract][Full Text] [Related]
14. Severe, isolated thrombocytopenia under polytherapy with carbamazepine and valproate. Finsterer J; Pelzl G; Hess B Psychiatry Clin Neurosci; 2001 Aug; 55(4):423-6. PubMed ID: 11442896 [TBL] [Abstract][Full Text] [Related]
15. Changes in red blood cells with valproate therapy. Ozkara C; Dreifuss FE; Apperson Hansen C Acta Neurol Scand; 1993 Sep; 88(3):210-2. PubMed ID: 8256557 [TBL] [Abstract][Full Text] [Related]
16. Prevalence and risk of thrombocytopenia with valproic acid: experience at a psychiatric teaching hospital. Conley EL; Coley KC; Pollock BG; Dapos SV; Maxwell R; Branch RA Pharmacotherapy; 2001 Nov; 21(11):1325-30. PubMed ID: 11714204 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the steady-state pharmacokinetics of topiramate and valproate in patients with epilepsy during monotherapy and concomitant therapy. Rosenfeld WE; Liao S; Kramer LD; Anderson G; Palmer M; Levy RH; Nayak RK Epilepsia; 1997 Mar; 38(3):324-33. PubMed ID: 9070595 [TBL] [Abstract][Full Text] [Related]
18. Systemic lupus erythematosus associated with use of valproate. Asconapé JJ; Manning KR; Lancman ME Epilepsia; 1994; 35(1):162-3. PubMed ID: 8112240 [TBL] [Abstract][Full Text] [Related]